It significantly decreased the IFN-γ-enhanced expression of HLA-C and immunogenicity of the melanoma cell lines, 1205Lu, WM278, and WM793 for the Vα3S1/Vβ13S1 TCR (Figure 3A–D). The gene discussed is HLA-C; the disease is melanoma.